Kelly Price has spent 28 years in the pharmaceutical industry with the last 15 years focused on transformative leadership in areas like digital therapeutics, market access innovation, direct to consumer launches, and patient centric commercial strategies. Currently serving as the Managing Director of US Operations, her strategic vision is guiding Esteve as they build the first US affiliate. Additionally, in her career, Kelly has helped to raise over 60 million in venture funding as well as been involved in M&A including the successful sale of HRA pharma to Esteve.